4//SEC Filing
Van Naarden Jacob 4
Accession 0000059478-23-000079
CIK 0000059478other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:35 PM ET
Size
9.2 KB
Accession
0000059478-23-000079
Insider Transaction Report
Form 4
Van Naarden Jacob
EVP & Pres., Lilly Oncology
Transactions
- Exercise/Conversion
Common Stock
2023-02-16+2,785→ 13,159 total - Tax Payment
Common Stock
2023-02-16$335.01/sh−1,314$440,203→ 11,845 total - Exercise/Conversion
Restricted Stock Unit
2023-02-16−2,785→ 0 totalFrom: 2023-02-16Exp: 2023-02-16→ Common Stock (2,785 underlying)
Holdings
- 4,342(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Documents
Issuer
ELI LILLY & Co
CIK 0000059478
Entity typeother
Related Parties
1- filerCIK 0001661254
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 4:35 PM ET
- Size
- 9.2 KB